Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases

Archives of Neurology

Volumn 54, Issue 11, 1997, Pages 1364-1368

  Chamberlain, Marc C ^a,b   Kormanik, Patty A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; HUMAN; LEPTOMENINX; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030728811     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550230037013     Document Type: Article

References (23)

1. Chamberlain MC. Current concepts in leptomeningeal metastasis. Curr Opin Oncol. 1992;4:533-539.
2. Chamberlain MC. New approaches to and current treatments of leptomeningeal metastases. Curr Opin Neurol. 1994;7:492-500.
3. Chamberlain MC. A review of leptomeningeal metastasis in pediatrics. J Child Neurol. 1995;10:191-199.
4. Shapiro W, Posner J, Ushio Y, Chernik N, Young D, Treatment of meningeal neoplasms. Cancer Treat Rep. 1977;61:733-743.
5. Wasserstrom W, Glass J, Posner J. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982;49: 759-772.
6. Grossman S, Moynihan T. Neurologic complications of systemic cancer: neoplastic meningitis. Neurol Clin. 1991;9:843-856.
7. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579-592.
8. Glantz M, Hall WA, Cole BF, et al. Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow studies. Cancer. 1995;75:2919-2931.
9. Chamberlain MC, Corey-Bloom J. Leptomeningeal metastasis: 111indiumDTPA CSF flow studies. Neurology. 1991;41:1765-1769.
10. 111indium-DTPA CSF flow studies in leptomeningeal metastasis. J Neurooncol. 1995;25:135-141.
11. Chamberlain MC. Comparative spine imaging in leptomeningeal metastases. J Neurooncol. 1995;23:233-238.
12. Chamberlain MC, Sandy A, Press GA. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology. 1990;40:435-438.
13. Lopez J, Nassif E, Vannicola P, Kirkorian J, Agarwal R. Central nervous system pharmacokinetics of high-dose cytosine arabinoside. J Neurooncol. 1985;3:119-124.
14. Ackland S, Schilsky R. High-dose methotrexate: a critical reappraisal. J Clin Oncol. 1987;5:2017-2031.
15. Chamberlain MC, Dirr L. Involved field radiotherapy and intra-Ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis. J Clin Oncol. 1993;11:1978-1993.
16. Fulton D, Levin V, Gutin P, et al. Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer Chemother Pharmacol. 1982;8:285-291.
17. Balis F, Poplack D. Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol. 1989;11:74-86.
18. Collins J. Pharmacokinetics of intraventricular administration. J Neurooncol. 1983; 1:283-291.
19. Gutin P, Levi J, Wiernik P, Walker M. Treatment of malignant meningeal disease with intrathecal thio-TEPA: a phase II study. Cancer Treat Rep. 1977;61:885-887.
20. 111indium-DTPA CSF flow studies. J Child Neurol. 1994;9:150-154.
21. Grossman SA, Trump DL, Chen DCP, Thompson G, Camargo EE. Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. Am J Med. 1982; 73:641-647.
22. Sze G, Abramson A, Krol G, et al. Gadolinium-DTPA in the evaluation of intradural extramedullary spinal disease. AJNR Am J Neuroradiol. 1988;9:153-163.
23. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid: cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995;38: 51-57.